Medicamen Biotech 33rd AGM: All 8 Resolutions Passed, Dividend Declared

Board & Shareholder Meetings View source PDF Explain this filing

MEDICAMEQ · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reaction · full curve 14 horizons · vs prior close

+2.8%1-day move

₹315.00

prior close

₹329.00

base price

In-mkt

timing

5m10m15m30m1D2D3D4D5D7D15D1M2M3M

-1.1+0.0+0.3-0.3+2.8+2.8+1.3-2.4-2.1-3.2————

Up moveDown movePending

AI summary

Medicamen Biotech held its 33rd AGM on September 26, 2026 via video conferencing. All 8 resolutions passed with over 99.99% approval. Key items: adoption of audited standalone and consolidated financial statements for FY ending March 2026, dividend declaration on equity shares, re-appointment of two directors, cost auditor pay ratification, and material related party deals with parent Shivalik Rasayan Limited and subsidiary Medicamen Life Sciences. Voting turnout was about 46%.

Likely market impact

All 8 resolutions passed with over 99.99% support including dividend and material related party deals with parent Shivalik Rasayan and subsidiary.